Supply Chain | November 16, 2025
Cenmed and Curavit team up to revolutionize clinical trial logistics
This collaboration turns kitting into a strategic advantage for sponsors and sites
This collaboration turns kitting into a strategic advantage for sponsors and sites
Diversifying its portfolio to include late-phase antiviral agent
False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
Net profit for the half-year rose to Rs. 410 crore from Rs. 351 crore
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
Relmada expects to initiate its Phase 3 program in the first half of 2026
Poviztra is a second brand of Wegovy
Sales from Novo’s GLP-1 portfolio—including Wegovy for obesity and Ozempic for type 2 diabetes reached $5.6 billion
This latest commitment brings the British pharmaceutical company’s total investment at the site to $886 million
Subscribe To Our Newsletter & Stay Updated
